Literature DB >> 2354913

Early tissue response to transscleral neodymium: YAG cyclophotocoagulation.

M Blasini1, R Simmons, M B Shields.   

Abstract

Transscleral cyclophotocoagulation was performed with a neodymium: YAG laser on five patients 24-72 hr before enucleation for a blind, painful eye. The thermal mode at 20 ms and a maximum offset between aiming and therapeutic beams were kept constant. Variable parameters evaluated were energy levels between 2 and 8 J and distance from the limbus of 0.5-3.0 mm. Because of the underlying distortion in three of the eyes, meaningful interpretation by light microscopic evaluation was possible only in the other two. This suggested that the early histologic hallmark of the procedure is similar to that previously observed in human autopsy eyes with ciliary epithelial damage and elevation from underlying tissue. In addition, fibrin and scant inflammatory cells were seen in the space between ciliary epithelium and stroma. Minimal damage was observed in the ciliary muscle. These findings suggest that direct damage to the ciliary epithelium is the most likely mechanism of reduced aqueous production by this cyclodestructive procedure. The findings also support the concept that an anterior placement of approximately 1.0-1.5 mm posterior to the limbus is most likely to damage the ciliary epithelium of the pars plicata.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2354913

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

1.  Clinical comparison of semiconductor diode versus neodymium: YAG non-contact cyclo photocoagulation.

Authors:  M W Ulbig; D A McHugh; A I McNaught; A M Hamilton
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

2.  Steps to optimize transscleral photocoagulation.

Authors:  P R Preussner; O Schwenn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-05       Impact factor: 3.117

3.  Excimer laser treatment for high and extreme myopia.

Authors:  H R Taylor; C A Carson
Journal:  Trans Am Ophthalmol Soc       Date:  1994

4.  Histopathologic observations on human eyes following neodymium: YAG laser cyclophotocoagulation for glaucoma.

Authors:  A P Ferry; M H King; D W Richards
Journal:  Trans Am Ophthalmol Soc       Date:  1995

5.  Real-time control for transscleral cyclophotocoagulation.

Authors:  P R Preussner; N Boos; K Fassbender; O Schwenn; N Pfeiffer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-12       Impact factor: 3.117

6.  The location of sites and effect of semiconductor diode trans-scleral cyclophotocoagulation on the buphthalmic equine globe.

Authors:  Anne J Gemensky-Metzler; David A Wilkie; Steven E Weisbrode; Sonia E Kuhn
Journal:  Vet Ophthalmol       Date:  2014-04-03       Impact factor: 1.644

7.  Noncontact transscleral Nd:YAG cyclophotocoagulation: a long-term follow-up of 500 patients.

Authors:  M B Shields; S E Shields
Journal:  Trans Am Ophthalmol Soc       Date:  1994

Review 8.  Evolution of Cyclophotocoagulation.

Authors:  Jideofor K Ndulue; Kamran Rahmatnejad; Carina Sanvicente; Sheryl S Wizov; Marlene R Moster
Journal:  J Ophthalmic Vis Res       Date:  2018 Jan-Mar

9.  Histologic Changes Following Continuous Wave and Micropulse Transscleral Cyclophotocoagulation: A Randomized Comparative Study.

Authors:  Kareem Moussa; Max Feinstein; Melike Pekmezci; Jun Hui Lee; Michele Bloomer; Catherine Oldenburg; Zhimin Sun; Richard K Lee; Gui-Shuang Ying; Ying Han
Journal:  Transl Vis Sci Technol       Date:  2020-04-28       Impact factor: 3.283

10.  Dose-response-relationship between number of laser burns and IOP reduction in cyclophotocoagulation: an animal study.

Authors:  Lars Wagenfeld; Hendrik Schwarzer; Gernot Roessler; Maren Klemm; Christos Skevas; Gisbert Richard; Oliver Zeitz
Journal:  Biomed Res Int       Date:  2014-06-29       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.